Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides
- PMID: 28167286
- DOI: 10.1016/j.jconrel.2017.02.006
Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides
Abstract
Efficient intracellular trafficking and targeted delivery to the site of action are essential to overcome the current drawbacks of cancer therapeutics. Cell Penetrating Peptides (CPPs) offer the possibility of efficient intracellular trafficking, and, therefore the development of drug delivery systems using CPPs as cargo carriers is an attractive strategy to address the current drawbacks of cancer therapeutics. Additionally, the possibility of incorporating Tumor Targeting Peptides (TTPs) into the delivery system provides the necessary drug targeting effect. Therefore the conjugation of CPPs and/or TTPs with therapeutics provides a potentially efficient method of improving intracellular drug delivery mechanisms. Peptides used as cargo carriers in DDS have been shown to enhance the cellular uptake of drugs and thereby provide an efficient therapeutic benefit over the drug on its own. After providing a brief overview of various drug targeting approaches, this review focusses on peptides as carriers and targeting moieties in drug-peptide covalent conjugates and summarizes the most recent literature examples where CPPs on their own or CPPs together with TTPs have been conjugated to anticancer drugs such as Doxorubicin, Methotrexate, Paclitaxel, Chlorambucil etc. A short section on CPPs used in multicomponent drug delivery systems is also included.
Keywords: Anticancer drug; Cell penetrating peptide; Cytotoxicity; Drug delivery; Integrin; Tumor targeting.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.Int J Nanomedicine. 2018 Mar 9;13:1425-1442. doi: 10.2147/IJN.S156616. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29563797 Free PMC article. Review.
-
Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.Anticancer Drugs. 2012 Jun;23(5):471-82. doi: 10.1097/CAD.0b013e32835065ed. Anticancer Drugs. 2012. PMID: 22241171 Review.
-
Cell-penetrating peptides: strategies for anticancer treatment.Trends Mol Med. 2015 Sep;21(9):560-70. doi: 10.1016/j.molmed.2015.06.005. Epub 2015 Jul 15. Trends Mol Med. 2015. PMID: 26186888 Review.
-
Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.Peptides. 2014 Jul;57:78-94. doi: 10.1016/j.peptides.2014.04.015. Epub 2014 Apr 30. Peptides. 2014. PMID: 24795041 Review.
-
Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.Bioconjug Chem. 2019 Jul 17;30(7):2011-2022. doi: 10.1021/acs.bioconjchem.9b00292. Epub 2019 Jun 19. Bioconjug Chem. 2019. PMID: 31243977
Cited by
-
SPA: a peptide antagonist that acts as a cell-penetrating peptide for drug delivery.Drug Deliv. 2020 Dec;27(1):91-99. doi: 10.1080/10717544.2019.1706669. Drug Deliv. 2020. PMID: 31870182 Free PMC article.
-
Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.Int J Mol Sci. 2018 Jan 9;19(1):195. doi: 10.3390/ijms19010195. Int J Mol Sci. 2018. PMID: 29315231 Free PMC article. Review.
-
Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue.J Nanobiotechnology. 2017 Oct 5;15(1):67. doi: 10.1186/s12951-017-0298-x. J Nanobiotechnology. 2017. PMID: 28982361 Free PMC article.
-
Recent advances in peptide-based nanomaterials for targeting hypoxia.Nanoscale Adv. 2021 Sep 3;3(21):6027-6039. doi: 10.1039/d1na00637a. eCollection 2021 Oct 27. Nanoscale Adv. 2021. PMID: 36133944 Free PMC article. Review.
-
TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.J Cancer Res Clin Oncol. 2019 Jun;145(6):1509-1519. doi: 10.1007/s00432-019-02921-3. Epub 2019 Apr 23. J Cancer Res Clin Oncol. 2019. PMID: 31016380
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources